MUTATIONS IN THE CONNEXIN-32 GENE IN X-LINKED DOMINANT CHARCOT-MARIE-TOOTH DISEASE (CMTX1)

被引:179
|
作者
FAIRWEATHER, N
BELL, C
COCHRANE, S
CHELLY, J
WANG, S
MOSTACCIUOLO, ML
MONACO, AP
HAITES, NE
机构
[1] UNIV ABERDEEN, SCH MED, DEPT MOLEC & CELL BIOL, ABERDEEN AB9 2ZD, SCOTLAND
[2] UNIV OXFORD, JOHN RADCLIFFE HOSP, INST MOLEC MED, ICRF LABS, OXFORD OX3 9DU, ENGLAND
[3] UNIV PENN, SCH MED, DEPT NEUROL, PHILADELPHIA, PA 19104 USA
[4] UNIV PADUA, DEPT BIOL, GENET LAB, PADUA, ITALY
关键词
D O I
10.1093/hmg/3.1.29
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
X-linked dominant Charcot-Marie-Tooth disease (CMTX1) is a peripheral neuropathy which maps to Xq13 and is flanked by the loci DXS106 (Xq11.2-q12) and DXS559 (Xq13.1). Contained within this interval of approximately 2-3Mb of DNA is the gene, connexin 32 (locus designation GJ beta 1). This gene encodes a gap junction protein which is expressed in large quantities within the liver and throughout a range of other mammmalian tissues. We have sequenced the coding region of exon 2 of this gene from affected individuals in nine families with CMTX 1 and have found mutations which segregate with the disease in eight of these families. The mutations detected include missense point mutations at codons 15, 60, 63, 208, and 215, a nonsense point mutation at codon 220, deletions of one base in codon 72/3 producing a stop codon 12 codons down stream and a three base pair deletion which can be predicted to result in the loss of a single amino acid. These findings are consistent with the disease CMTX1 being the result of mutations affecting the gene connexin 32 (Cx32).
引用
收藏
页码:29 / 34
页数:6
相关论文
共 50 条
  • [21] A new de novo mutation of the connexin-32 gene in a patient with X-linked Charcot-Marie-Tooth type 1 disease
    Di Iorio, G
    Cappa, V
    Ciccodicola, A
    Sampaolo, S
    Ammendola, A
    Sanges, G
    Giugliano, R
    D'Urso, M
    NEUROLOGICAL SCIENCES, 2000, 21 (02) : 109 - 112
  • [22] X-LINKED DOMINANT CHARCOT-MARIE-TOOTH NEUROPATHY - VALINE-38-METHIONINE SUBSTITUTION OF CONNEXIN-32
    ORTH, U
    FAIRWEATHER, N
    EXLER, MC
    SCHWINGER, E
    GAL, A
    HUMAN MOLECULAR GENETICS, 1994, 3 (09) : 1699 - 1700
  • [23] X-linked dominant Charcot-Marie-Tooth disease: Novel connexin 32 mutations and their relationship to clinical and pathological disease
    Tan, CC
    Ainsworth, PJ
    Ionasescu, V
    Bolton, CF
    Hahn, AF
    ANNALS OF NEUROLOGY, 1996, 40 (03) : T215 - T215
  • [24] Mutations of the noncoding region of the connexin 32 gene in X-linked Charcot-Marie-Tooth neuropathy
    Ionasescu, VV
    Searby, C
    Ionasescu, R
    Neuhaus, I
    Werner, R
    NEUROLOGY, 1996, 46 (02) : 2010 - 2010
  • [25] POINT MUTATIONS OF THE CONNEXIN32 (GJB1) GENE IN X-LINKED DOMINANT CHARCOT-MARIE-TOOTH NEUROPATHY
    IONASESCU, V
    SEARBY, C
    IONASESCU, R
    HUMAN MOLECULAR GENETICS, 1994, 3 (02) : 355 - 358
  • [26] FUNCTIONAL-CHARACTERIZATION OF MUTATIONS IN X-LINKED CHARCOT-MARIE-TOOTH DISEASE (CMTX)
    DESCHENES, SM
    SPRAY, DC
    FISCHBECK, KH
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 38 - 38
  • [27] NULL MUTATIONS OF CONNEXIN32 IN PATIENTS WITH X-LINKED CHARCOT-MARIE-TOOTH DISEASE
    BRUZZONE, R
    WHITE, TW
    SCHERER, SS
    FISCHBECK, KH
    PAUL, DL
    NEURON, 1994, 13 (05) : 1253 - 1260
  • [28] NEW CONNEXIN32 MUTATIONS ASSOCIATED WITH X-LINKED CHARCOT-MARIE-TOOTH DISEASE
    BONE, LJ
    DAHL, N
    LENSCH, MW
    CHANCE, PF
    KELLY, T
    LEGUERN, E
    MAGI, S
    PARRY, G
    SHAPIRO, H
    WANG, S
    FISCHBECK, KH
    NEUROLOGY, 1995, 45 (10) : 1863 - 1866
  • [29] NULL MUTATIONS OF CONNEXIN32 IN PATIENTS WITH X-LINKED CHARCOT-MARIE-TOOTH DISEASE
    PAUL, DL
    BRUZZONE, R
    JOURNAL OF GENERAL PHYSIOLOGY, 1994, 104 (06): : A56 - A56
  • [30] X-linked Charcot-Marie-Tooth disease with connexin 32 mutations -: Clinical and electrophysiologic study
    Birouk, N
    LeGuern, E
    Maisonobe, T
    Rouger, H
    Gouider, R
    Tardieu, S
    Gugenheim, M
    Routon, MC
    Léger, JM
    Agid, Y
    Brice, A
    Bouche, P
    NEUROLOGY, 1998, 50 (04) : 1074 - 1082